Search

everythinglearnresearchcommunity

for

Search:↓

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Estrogen therapy can reduce skin aging but has cancer risks.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

Bald-headed individuals may need early non-invasive detection for skin changes linked to cancer risk.

Acer1 is essential for skin health and affects hair growth and skin cancer risk.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.